Notice of Preliminary Results | 01-Oct-2024 | 07:00 | RNS |
Director/PDMR Shareholding | 20-Sep-2024 | 07:00 | RNS |
Exercise of Share Options and Total Voting Rights | 19-Sep-2024 | 13:13 | RNS |
FDA 510(k) submission for Tristel OPH | 12-Sep-2024 | 07:00 | RNS |
Confirmation of CEO Transition, Directorate Change | 02-Sep-2024 | 07:00 | RNS |
Exercise of Share Options and Total Voting Rights | 06-Aug-2024 | 15:32 | RNS |
Trading Update | 22-Jul-2024 | 07:00 | RNS |
Exercise of Share Options and Total Voting Rights | 04-Jul-2024 | 15:43 | RNS |
Director/PDMR Shareholding | 11-Jun-2024 | 17:48 | RNS |
Holding(s) in Company | 11-Jun-2024 | 15:50 | RNS |
Appointment of CEO | 10-Jun-2024 | 07:00 | RNS |
Exercise of Share Options and Total Voting Rights | 07-May-2024 | 07:00 | RNS |
Director/PDMR Shareholding | 16-Apr-2024 | 14:04 | RNS |
Exercise of Share Options and Total Voting Rights | 15-Apr-2024 | 17:56 | RNS |
Exercise of Share Options and Total Voting Rights | 19-Mar-2024 | 09:25 | RNS |
Currency | UK Pounds |
Share Price | 370.00p |
Change Today | -10.00p |
% Change | -2.63 % |
52 Week High | 500.00 |
52 Week Low | 367.50 |
Volume | 53,375 |
Shares Issued | 47.65m |
Market Cap | £176.31m |
Beta | 0.01 |
RiskGrade | 180 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 2 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 21-Mar-24 | 23-Nov-23 |
Paid | 12-Apr-24 | 22-Dec-23 |
Amount | 5.24p | 7.88p |
Time | Volume / Share Price |
15:39 | 10,000 @ 370.00p |
16:26 | 2,500 @ 370.00p |
16:04 | 3,000 @ 372.00p |
15:49 | 2,500 @ 370.00p |
15:47 | 1,300 @ 371.00p |
Finance Director | Elizabeth Dixon |
CEO | Matthew (Matt) Giovanni Sassone |
You are here: research